Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.46 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.46 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.46 |
| ▸ | TRPV6 | Q9H1D0 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4928266 | 0.85 | ORAI1 (0.39) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL8396426 | 0.83 | KDM4E (0.47) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL28230966 | 0.79 | ORAI1 (0.34) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL28430844 | 0.76 | CA4 (0.48) | CA4CA7CA14ENPP2ALDH1A1 | |
| SCHEMBL28363887 | 0.76 | CA1 (0.40) | ORAI1ORAI2ORAI3TRPV6ALDH1A1 | |
| SCHEMBL16549328 | 0.72 | ENPP2 (0.48) | CA4CA6CA5ACA14CA5B | |
| SCHEMBL56106 | 0.72 | TRPV6 (0.50) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL263612 | 0.71 | ORAI1 (0.52) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL309077 | 0.71 | CA4 (0.48) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL2744416 | 0.71 | ORAI1 (0.46) | ORAI1ORAI2ORAI3TRPV6CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574335-A | Photo-curing resin, high-toughness adhesive product and preparation method thereof | 万华化学集团股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-113136020-A | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-121574335-A | Photo-curing resin, high-toughness adhesive product and preparation method thereof | 万华化学集团股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-113136020-B | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-113136020-A | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-07-20 | — | — | CN | disclosed |
| US-10617706-B2 | Compounds for cancer chemotherapeutic sensitization | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2020-04-14 | — | — | US | disclosed |
| US-20190240244-A1 | COMPOUNDS FOR CANCER CHEMOTHERAPEUTIC SENSITIZATION | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2019-08-08 | — | — | US | disclosed |
| US-8048680-B2 | Holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-11-01 | — | — | US | disclosed |
| EP-1187676-B1 | APPARATUS FOR CONDUCTING AN ASSAY | PROVALIS DIAGNOSTICS LTD (GB) | 2004-10-06 | — | — | EP | disclosed |
| US-6677158-B2 | DETECTION OF GLYCATED HEMOGLOBIN; OBTAIN SAMPLE, INCUBATE WITH PAD, ELUTE, INCUBATE WITH MEMBRANE, MONITOR INTENSITY OF HEMOGLOBIN COLOR, DETERMINE THE RATION OF GLYCATED TO NON-GLYCATED HEMOGLOBIN | EXOCELL INC. | 2004-01-13 | — | — | US | disclosed |
| US-20020164811-A1 | Novel method for measurement of glycated hemoglobin by a rapid strip test procedure | EXOCELL, INC. | 2002-11-07 | — | — | US | disclosed |
| EP-1187676-A1 | APPARATUS, INSTRUMENT AND DEVICE FOR CONDUCTING AN ASSAY | Provalis Diagnostics Limited (GB) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000076663-A1 | APPARATUS, INSTRUMENT AND DEVICE FOR CONDUCTING AN ASSAY | PROVALIS DIAGNOSTICS LIMITED (GB) | 2000-12-21 | — | — | WO | disclosed |
| US-5763203-A | Immobilization and separation of cells and other particles | SINVENT AS (NO) | 1998-06-09 | — | — | US | disclosed |
| EP-0688430-B1 | IMMOBILISATION AND SEPARATION OF CELLS AND OTHER PARTICLES | SINVENT AS (NO) | 1997-05-28 | — | — | EP | disclosed |
| EP-0688430-A1 | IMMOBILISATION AND SEPARATION OF CELLS AND OTHER PARTICLES | SINVENT AS (NO) | 1995-12-27 | — | — | EP | disclosed |
| WO-1994020858-A1 | IMMOBILISATION AND SEPARATION OF CELLS AND OTHER PARTICLES | SINVENT A/S (NO) | 1994-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10617706-B2 | Compounds for cancer chemotherapeutic sensitization | ABCC1, MCL1, ABCC3 | ORAI1 4230/4885ORAI2 4231/4885ORAI3 2719/4885 |
| US-20190240244-A1 | COMPOUNDS FOR CANCER CHEMOTHERAPEUTIC SENSITIZATION | ABCC1, MCL1, ABCC3 | ORAI1 4230/4885ORAI2 4231/4885ORAI3 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.